Codice QR

The efficacy of generic imatinib in patients with chronic myeloid leukemia: A single centre experience

Background/Aim. The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of targeted therapies. This study aimed to assess the efficacy of generic imatinib in CML patients treated in our center. Methods. The study was retrospective. It included 101 patients diagnosed...

Descrizione completa

Salvato in:
Autori principali: Urošević Ivana, Perčić Ivanka, Dragičević-Jojkić Marina, Dokić Marina, El Farra Amir, Savić Aleksandar, Milošević Ivana, Vlaisavljević Nada, Sekulić Borivoj, Balint Bela
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
Serie:Vojnosanitetski Pregled
Soggetti:
leukemia, myeloid, chronic-phase
imatinib mesylate
drugs, generic
survival
Accesso online:http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84501900095U.pdf
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi